Our findings suggest that S100A4 accelerates tumor progression and promotes chemoresistance through the modulation of proliferation, susceptibility to apoptosis, and epithelial–mesenchymal transition/cancer stem cell properties. The gene discussed is S100A4; the disease is neoplasm.